Defining the molecular and functional features of protective HIV-specific T cells

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1106756

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Human immunodeficiency virus (HIV) directly attacks our immune system, impairing our natural defense against infection and disease. HIV has claimed over 39 million lives worldwide since its discovery, and no vaccine is currently available. Despite this, there are some individuals with a particular genetic advantage able to control HIV infection who never get sick. Understanding how these individuals control HIV so efficiently may lead to novel treatments or potential vaccines against HIV.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $591,966.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Structural Biology (incl. Macromolecular Modelling)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

T cell receptor | X-ray crystallography | human immunodeficiency virus (HIV) | human leukocyte antigen (HLA) | structural immunology

Related Links